Legal & General Group’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.1K | Buy |
5,422
+1,417
| +35% | +$6.04K | ﹤0.01% | 2950 |
|
|
2025
Q1 | $15.1K | Sell |
4,005
-25,711
| -87% | -$96.7K | ﹤0.01% | 3045 |
|
|
2024
Q4 | $173K | Hold |
29,716
| – | – | ﹤0.01% | 2678 |
|
|
2024
Q3 | $355K | Buy |
29,716
+307
| +1% | +$3.67K | ﹤0.01% | 2569 |
|
|
2024
Q2 | $318K | Buy |
29,409
+2,115
| +8% | +$22.9K | ﹤0.01% | 2580 |
|
|
2024
Q1 | $309K | Buy |
27,294
+2,761
| +11% | +$31.3K | ﹤0.01% | 2598 |
|
|
2023
Q4 | $344K | Buy |
24,533
+22,106
| +911% | +$310K | ﹤0.01% | 2583 |
|
|
2023
Q3 | $30K | Sell |
2,427
-153
| -6% | -$1.89K | ﹤0.01% | 2922 |
|
|
2023
Q2 | $23.3K | Buy |
+2,580
| New | +$23.3K | ﹤0.01% | 3052 |
|
|
2022
Q2 | – | Sell |
-4,749
| Closed | -$20K | – | 3617 |
|
|
2022
Q1 | $20K | Sell |
4,749
-550
| -10% | -$2.32K | ﹤0.01% | 3242 |
|
|
2021
Q4 | $49K | Buy |
5,299
+3,007
| +131% | +$27.8K | ﹤0.01% | 3036 |
|
|
2021
Q3 | $63K | Buy |
2,292
+1,150
| +101% | +$31.6K | ﹤0.01% | 2927 |
|
|
2021
Q2 | $32K | Sell |
1,142
-103
| -8% | -$2.89K | ﹤0.01% | 3113 |
|
|
2021
Q1 | $41K | Buy |
+1,245
| New | +$41K | ﹤0.01% | 2882 |
|